Medical cannabis company Cann Group
(ASX:CAN) has been granted import permits by the Therapeutic Goods Administration (TGA).
The permits will allow the company to begin the import of genetics and cannabis oils from its Canadian partners.
Cann will bring four products developed by Aurora Canabis to Australia, which will be made available to medical practitioners seeking to provide medicinal cannabis to patients.
The company says the ability to import genetics will improve its ability to cultivate various strains of medicinal cannabis.
Shares in Cann Group
(ASX:CAN) are trading 4.67 per cent higher to $3.14.
